Continuous Glucose Monitoring-guided Insulin Dosing in Pump-treated Patients with Type 1 Diabetes: a Clinical Guide

Overview

Journal J Diabetes Sci Technol

Specialty Endocrinology

Date 2012 Mar 10

PMID 22401339

Citations 6

Authors

Allen B King

Affiliations

Soon will be listed here.

Abstract

This article describes our methods for structured continuous glucose monitoring (CGM)-guided insulin dosing in pump-treated type 1 diabetes. Some of the methods have been reported and some are based on clinical experience. It is expected that this guide will help those involved in the care of such patients and who have experience with CGM to achieve better glucose control in their patients. More research needs to be done on insulin dosing and we hope that this article will also encourage others to pursue this field. This is a guide and, as such, is not meant to replace clinical judgment. Also, these dosing approaches apply only to those patients on pump therapy. They do not necessarily carry over to those patients treated with basal analog insulin.

Citing Articles

Insulin pumps in children - a systematic review.

Al-Beltagi M, Saeed N, Bediwy A, Elbeltagi R World J Clin Pediatr. 2022; 11(6):463-484.

PMID: 36439904 PMC: 9685680. DOI: 10.5409/wjcp.v11.i6.463.

Diurnal Variation of Real-Life Insulin Sensitivity Factor Among Children and Adolescents With Type 1 Diabetes Using Ultra-Long-Acting Basal Insulin Analogs.

Hegab A Front Pediatr. 2022; 10:854972.

PMID: 35350271 PMC: 8957904. DOI: 10.3389/fped.2022.854972.

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes.

King A, Kuroda A, Matsuhisa M, Hobbs T Curr Diab Rep. 2016; 16(9):83.

PMID: 27457238 PMC: 4960276. DOI: 10.1007/s11892-016-0772-0.

CGM Retrospective Data Analysis.

Scheiner G Diabetes Technol Ther. 2016; 18 Suppl 2:S214-22.

PMID: 26784125 PMC: 4717507. DOI: 10.1089/dia.2015.0281.

Carbohydrate-to-Insulin Ratio in a Mediterranean Population of Type 1 Diabetic Patients on Continuous Subcutaneous Insulin Infusion Therapy.

Alcantara-Aragon V, Gonzalez C, Corcoy R, Ubeda J, Chico A J Diabetes Sci Technol. 2014; 9(3):588-92.

PMID: 25519294 PMC: 4604542. DOI: 10.1177/1932296814563571.

References

King A, Armstrong D . A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: bolus dosing. J Diabetes Sci Technol. 2009; 1(1):42-6. PMC: 2769601. DOI: 10.1177/193229680700100107. View

Halfon P, Belkhadir J, Slama G . Correlation between amount of carbohydrate in mixed meals and insulin delivery by artificial pancreas in seven IDDM subjects. Diabetes Care. 1989; 12(6):427-9. DOI: 10.2337/diacare.12.6.427. View

King A . Minimal reduction in insulin dosage with pramlintide therapy when pretreatment near-normal glycemia is established and square-wave meal bolus is used. Endocr Pract. 2009; 15(3):229-33. DOI: 10.4158/EP.15.3.229. View

Pankowska E . A review of the "bolus guide," a new insulin bolus dosing support tool based on selection of carbohydrate ranges. J Diabetes Sci Technol. 2010; 4(4):903-5. PMC: 2909522. DOI: 10.1177/193229681000400419. View

Heinemann L . Insulin pump therapy: what is the evidence for using different types of boluses for coverage of prandial insulin requirements?. J Diabetes Sci Technol. 2010; 3(6):1490-500. PMC: 2787051. DOI: 10.1177/193229680900300631. View

King A . How much do I give? Reevaluation of insulin dosing estimation formulas using continuous glucose monitoring. Endocr Pract. 2010; 16(3):428-32. DOI: 10.4158/EP09308.OR. View

King A, Armstrong D . A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: Basal dosing. J Diabetes Sci Technol. 2009; 1(1):36-41. PMC: 2769604. DOI: 10.1177/193229680700100106. View

Heinemann L, Nosek L, Kapitza C, Schweitzer M, Krinelke L . Changes in basal insulin infusion rates with subcutaneous insulin infusion: time until a change in metabolic effect is induced in patients with type 1 diabetes. Diabetes Care. 2009; 32(8):1437-9. PMC: 2713639. DOI: 10.2337/dc09-0595. View

Rabasa-Lhoret R, Garon J, Langelier H, Poisson D, Chiasson J . Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente-regular) insulin regimen. Diabetes Care. 1999; 22(5):667-73. DOI: 10.2337/diacare.22.5.667. View

10.

Becker R, Frick A, Nosek L, Heinemann L, Rave K . Dose-response relationship of insulin glulisine in subjects with type 1 diabetes. Diabetes Care. 2007; 30(10):2506-7. DOI: 10.2337/dc06-2114. View

11.

King A . Comparison of the post-meal glucose response to different insulin bolus waveforms in insulin pump- and pre-meal pramlintide-treated type 1 diabetes patients. Diabetes Technol Ther. 2010; 12(2):105-8. DOI: 10.1089/dia.2009.0096. View

12.

Moberg E, Kollind M, Lins P, Adamson U . Day-to-day variation of insulin sensitivity in patients with type 1 diabetes: role of gender and menstrual cycle. Diabet Med. 1995; 12(3):224-8. DOI: 10.1111/j.1464-5491.1995.tb00462.x. View

13.

Davidson P, Hebblewhite H, Steed R, Bode B . Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio. Endocr Pract. 2009; 14(9):1095-101. DOI: 10.4158/EP.14.9.1095. View

14.

Van Cauter E, Polonsky K, Scheen A . Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev. 1997; 18(5):716-38. DOI: 10.1210/edrv.18.5.0317. View

15.

Rasmussen O . Dose-dependency of the glycemic response to starch-rich meals in insulin-dependent diabetic subjects: studies at constant insulinemia. Metabolism. 1993; 42(6):710-3. DOI: 10.1016/0026-0495(93)90237-i. View

16.

Kaufman F, Gibson L, Halvorson M, Carpenter S, Fisher L, Pitukcheewanont P . A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care. 2001; 24(12):2030-4. DOI: 10.2337/diacare.24.12.2030. View

17.

Peters A, Davidson M . Protein and fat effects on glucose responses and insulin requirements in subjects with insulin-dependent diabetes mellitus. Am J Clin Nutr. 1993; 58(4):555-60. DOI: 10.1093/ajcn/58.4.555. View

18.

Boland E, Monsod T, Delucia M, Brandt C, Fernando S, Tamborlane W . Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care. 2001; 24(11):1858-62. DOI: 10.2337/diacare.24.11.1858. View

19.

Franz M . The glycemic index: not the most effective nutrition therapy intervention. Diabetes Care. 2003; 26(8):2466-8. DOI: 10.2337/diacare.26.8.2466. View

20.

. Standards of medical care in diabetes--2010. Diabetes Care. 2010; 33 Suppl 1:S11-61. PMC: 2797382. DOI: 10.2337/dc10-S011. View